Rachel Bahr is a transformative leader committed to advancing the health of both people and animals. As CEO of Ardent Animal Health, she drives breakthroughs in regenerative medicine that help pets live longer, healthier lives while contributing to scientific progress with implications for human health. At the same time, as CEO of Xiogenix, Rachel leads teams at the forefront of biomanufacturing innovation—delivering equipment, services, and solutions that power cell and gene therapy, tissue banking, and beyond.
With a career spanning privately held, public, and employee-owned companies, Rachel has earned a reputation for building strong cultures, developing high-performing teams, and leading organizations through growth and transformation. Her leadership philosophy is rooted in trust, transparency, and accountability—ensuring people and organizations thrive together.